LifeMD Inc
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
LFMD$1.74-16.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
CONDENSED Consolidated STATEMENTS of CHANGES IN STOCKHOLDERS’ EQUITY (Deficit)
| LifeMD, Inc. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred Stock · Common Stock · Additional Paid-in · Accumulated · Treasury · Non- controlling | ||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Stock | Total | Interest | Total | |
| Balance, January 1, 2024 | 1,400,000 | $140 | 38,358,641 | $383,586 | $217,550,583 | $(214,265,236) | $(163,701) | $3,505,372 | $2,060,787 | $5,566,159 |
| Stock compensation expense | - | - | 943,375 | 9,434 | 2,534,996 | - | - | 2,544,430 | - | 2,544,430 |
| Stock issued for noncontingent consideration payment | - | - | 95,821 | 958 | 641,042 | - | - | 642,000 | - | 642,000 |
| Exercise of stock options | - | - | 1,250 | 13 | 7,800 | - | - | 7,813 | 7,813 | |
| Cashless exercise of warrants | - | - | 1,268,476 | 12,685 | (12,685) | - | - | - | - | - |
| Cashless exercise of options | - | - | 64,113 | 641 | (641) | - | - | - | - | - |
| Series A Preferred Stock Dividend | - | - | - | - | - | (776,563) | - | (776,563) | - | (776,563) |
| Distribution to non-controlling interest | - | - | - | - | - | - | - | - | (36,000 | (36,000) |
| Net (loss) income | - | - | - | - | - | (6,768,355) | - | (6,768,355) | 119,432 | (6,648,923) |
| Balance, March 31, 2024 | 1,400,000 | $140 | 40,731,676 | $407,317 | $220,721,095 | $(221,810,154) | $(163,701) | $(845,303) | $2,144,219 | $1,298,916 |
| LifeMD, Inc. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred Stock · Common Stock · Additional Paid-in · Accumulated · Treasury · Non- controlling | ||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Stock | Total | Interest | Total | |
| Balance, January 1, 2025 | 1,400,000 | $140 | 42,293,907 | $422,939 | $230,508,339 | $(236,253,218) | $(163,701) | $(5,485,501) | $1,440,133 | $(4,045,368) |
| Stock compensation expense | - | - | 1,282,654 | 12,827 | 2,535,701 | - | - | 2,548,528 | - | 2,548,528 |
| Cashless exercise of options | - | - | 56,139 | 561 | (561) | - | - | - | - | - |
| Series A Preferred Stock Dividend | - | - | - | - | - | (776,563) | - | (776,563) | - | (776,563) |
| Distribution to non-controlling interest | - | - | - | - | - | - | - | - | (36,000) | (36,000) |
| Net income | - | - | - | - | - | 1,384,804 | - | 1,384,804 | 531,845 | 1,916,649 |
| Balance, March 31, 2025 | 1,400,000 | $140 | 43,632,700 | $436,327 | $233,043,479 | $(235,644,977) | $(163,701) | $(2,328,732) | $1,935,978 | $(392,754) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.